User profiles for Mayron Antonio Candia-Puma

Mayron A. Candia-Puma

Investigador en Ciencias de la Salud, Universidad Católica de Santa María
Verified email at ucsm.edu.pe
Cited by 29

[HTML][HTML] Accuracy of diagnostic tests for the detection of Chagas disease: A systematic review and meta-analysis

MA Candia-Puma, LY Machaca-Luque… - Diagnostics, 2022 - mdpi.com
The present systematic review and meta-analysis about the accuracy of diagnostic tests aim
to describe the findings of literature over the last thirty years for the diagnosis of Chagas …

[HTML][HTML] PeruNPDB: The Peruvian natural products database for in silico drug screening

…, LG Ranilla, MA Candia-Puma… - Scientific Reports, 2023 - nature.com
Since the number of drugs based on natural products (NPs) represents a large source of
novel pharmacological entities, NPs have acquired significance in drug discovery. Peru is …

[HTML][HTML] Computer-aided drug design approaches applied to screen natural product's structural analogs targeting arginase in Leishmania spp

HL Barazorda-Ccahuana, LD Goyzueta-Mamani… - …, 2023 - ncbi.nlm.nih.gov
Introduction: Leishmaniasis is a disease with high mortality rates and approximately 1.5
million new cases each year. Despite the new approaches and advances to fight the disease, …

A Mini-Review on Elisa-Based Diagnosis of Schistosomiasis

…, F Ludolf, MA Candia-Puma… - Current Molecular …, 2024 - ingentaconnect.com
Background: Schistosomiasis is a neglected tropical parasitic disease caused by trematode
worms of the genus schistosoma, which affects approximately 240 million people worldwide. …

[HTML][HTML] Peruvian contributions to scientific publications on experimental research against COVID-19: a systematic review

K Coronel-Monje, MA Candia-Puma… - …, 2023 - f1000research.com
Background One of the countries most adversely affected by the COVID-19 outbreak was
Peru. Worldwide scientific knowledge creation has significantly grown because of this …

In silico-based screening for natural product's structural analogs as new drugs candidate against leishmaniasis

…, LD Goyzueta-Mamani, MA Candia-Puma… - bioRxiv, 2022 - biorxiv.org
Leishmaniasis is a disease with high mortality rates and approximately 1.5 million new cases
each year. Despite the new approaches and advances to fight the disease, there are no …

[HTML][HTML] A systematic review and meta-analysis comparing the diagnostic accuracy tests of COVID-19

JJ Vilca-Alosilla, MA Candia-Puma, K Coronel-Monje… - Diagnostics, 2023 - mdpi.com
In this paper, we present a systematic review and meta-analysis that aims to evaluate the
reliability of coronavirus disease diagnostic tests in 2019 (COVID-19). This article seeks to …

Treatment options for Chagas Disease: a systematic review and meta-analysis applied to the preclinical studies using animal models

LY Machaca Luque, MA Candia Puma… - bioRxiv, 2024 - biorxiv.org
Chagas disease (CD) is a neglected tropical disease endemic to Latin America and has
emerged as a global health concern due to the migration of infected individuals. With its …

A Systematic Review of Peruvian Contributions to Scientific Publications on Experimental Research Against COVID-19

K Coronel-Monje, MA Candia-Puma, JJ Vilca-Alosilla… - medRxiv, 2023 - medrxiv.org
One of the countries most adversely affected by the COVID-19 outbreak was Peru. Worldwide
scientific knowledge creation has significantly grown because of this pandemic. This …

[PDF][PDF] to screen natural product's structural analogs targeting arginase in Leishmania spp [version 3; peer review: 2

HL Barazorda-Ccahuana, LD Goyzueta-Mamani… - 2023 - researchgate.net
Introduction: Leishmaniasis is a disease with high mortality rates and approximately 1.5
million new cases each year. Despite the new approaches and advances to fight the disease, …